5th ESO Arab Countries Masterclass in Clinical Oncology

Chairs: M.S. Aapro, CH - N. Pavlidis, GR - S. Khatib, JO
Host country chairs: H. Khaled, EG - M. Lotayef, EG


This is a 3-days clinically oriented educational programme dedicated to medical, clinical and radiation oncologists, who wish to improve their skills in oncology or those who are preparing for the national board exam. The programme focuses on breast, gynaecological, prostate, colorectal, lung cancers and on lymphomas and its covered by an international faculty of top experts.

The Masterclass offers:

• plenary lectures regarding state-of-the art clinical evaluation and treatments with reference to clinical guidelines concluding in takehome messages,
• clinical case presentations will be delivered by the participants in tumor board discussions as well as in divided small groups with the presence of the chairs and the faculty,
• a self-assessment test based on multiple choice questionnaire, will be provided to participants on the last day of the Masterclass

All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and fluency in English is necessary for admission


LEARNING OBJECTIVES
• Improve medical oncologists’ skills
• Practicing case discussion
• Deep focus on breast, gynaecological, prostate, lung and colorectal cancer, lymphomas


MAIN TOPICS
• Breast cancer
• Gynaecological cancer
• Prostate cancer
• Colorectal cancer
• Lung cancer
• Lymphomas

Held under the auspices of:

ORGANISING SECRETARIAT
Daniela Mengato
European School of Oncology (ESO)
Via Turati 29 - 20121 Milan, Italy
Tel:
Fax: +39 02 85464545
Email: dmengato@eso.net+39 02 85464532


APPLICATIONS
Elena Fiore
Ph: +39 02 85464529
Email: efiore@eso.net

FACULTY
M.S. Aapro, Clinique de Genolier, Geneve, CH
N. Allahloubi, National Cancer Institute, Cairo University, EG
S. Al-Sukhun, Consultant in Medical Oncology and Hematology, Amman, JO
H.A. Azim Jr., Innate Pharma, Marseille, FR
M. El Naggar, National Cancer Institute, Cairo University, EG
R. Gaafar, National Cancer Institute, Cairo University, EG
F. Geara, American University of Beirut Medical Center, LB
J. Gligorov, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, FR
J. Khader, King Hussein Cancer Centre, Amman, JO
H. Khaled, National Cancer Institute, Cairo University, EG
S. Khatib, Arab Medical Association Against Cancer (AMAAC), Amman, JO
M. Lotayef, National Cancer Institute, Cairo University, EG
O. Mansour, National Cancer Institute, Cairo University, EG
N. Mottet, University Hospital, Saint Etienne, FR
O. Pagani, Oncology Institute of Southern Switzerland, Bellinzona, CH
N. Pavlidis, University of Ioannina, School of Medicine, Ioannina, GR
A. Shamseddine, American University of Beirut Medical Center, LB
J. Souglakos, University Hospital of Heraklion, GR
A. Stathis, Oncology Institute of Southern Switzerland, Bellinzona, CH
J. B. Vermorken, University Hospital of Antwerp, Edegem, BE
O. Z. Youssef, National Cancer Institute, Cairo University, EG

28 OCTOBER

29 OCTOBER

30 OCTOBER